Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001415889-25-001923

Options or other derivatives

  • PRESIDENT AND CEO acquired 730,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · PRESIDENT AND CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-21 Grant or award : show line 1 in the form Stock Option (right to buy) +730,000 730,000 D
Loading xslF345X05/form4-01232025_040101.xml…